Levothyroxine sodium/OmalizumabVarious toxicities and off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2041卷 / 1期

关键词：

D O I：

10.1007/s40278-025-74598-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：209 / 209

相关论文

共 50 条

[1] Levothyroxine-sodium/SintilimabVarious toxicities, lack of efficacy and off-label use: case report
Reactions Weekly, 2024, 2027 (1) : 256 - 256
[2] Sodium oxybateVarious toxicities following off label use: case report
Reactions Weekly, 2019, 1753 (1) : 311 - 311
[3] OmalizumabVarious toxicities: case report
Reactions Weekly, 2015, 1556 (1) : 205 - 205
[4] OmalizumabVarious toxicities: case report
Reactions Weekly, 2011, 1339 (1) : 30 - 30
[5] Levothyroxine sodium/tofacitinibOff label use and various toxicities: 11 case reports
Reactions Weekly, 2019, 1770 (1) : 239 - 239
[6] AntineoplasticsVarious toxicities and off label use: case report
Reactions Weekly, 2023, 1960 (1) : 55 - 55
[7] ThalidomideVarious toxicities and off label use: case report
Reactions Weekly, 2022, 1910 (1) : 440 - 440
[8] AntineoplasticsVarious toxicities and off label use: case report
Reactions Weekly, 2020, 1798 (1) : 40 - 40
[9] AntineoplasticsVarious toxicities and off label use: case report
Reactions Weekly, 2022, 1888 (1) : 62 - 62
[10] Levothyroxine sodium abuseVarious toxicities: case report
Reactions Weekly, 2019, 1781 (1) : 219 - 219

← 1 2 3 4 5 →